Skip to main content

Table 1 Baseline characteristics of children enrolled for the study

From: Efficacy and safety of the syrup “KalobaTUSS®” as a treatment for cough in children: a randomized, double blind, placebo-controlled clinical trial

 

KalobaTUSS®

Placebo

Whole sample

Statistics

Children n.

54

52

106

 

Mean age (months)

53.2 ± 11.8

52.9 ± 12.3

53.0 ± 12.0

NS

Median age (months)

52

51.5

52

__

Sex (male/female)

28/26

26/26

54/52

NS

Consecutive days of cough before recruitment

3.53 ± 0.57

3.52 ± 0.58

3.59 ± 0.65

NS

  1. Data are expressed as means ± standard deviation. NS Not significant